John Neppl
Analyst · Credit Suisse. Please go ahead with your question
Thanks, Greg. Good morning, everyone. Let's turn to the earnings highlights in slide six. Our reported third quarter earnings per share from continuing operations was a loss of $10.57 compared to a gain of $2.39 in the third quarter of 2018. Adjusted EPS was $1.41 in Q3 versus $2.52 in the prior year. Our reported results included approximately $1.7 billion in charges related to portfolio initiatives, primarily consisting of approximately $1.6 billion of impairment and other charges related to our Brazilian sugarcane milling business. As shown on the next slide, as a result of this impairment, total shareholders' equity has been temporarily reduced by approximately $1.5 billion, reflecting the impairment loss recorded in the period. When the transaction closes later this year, the related $1.5 billion of cumulative translation adjustment balance will be released, effectively increasing shareholders' equity by that amount. In addition to the sugar impairment, we incurred $137 million of other charges in the quarter, primarily related to impairments and severance in our other segments as part of a broader portfolio review. Total segment EBIT was a loss of $1.44 billion in the quarter versus EBIT of $535 million in the prior-year. On an adjusted basis, which excludes notables, total segment EBIT was $304 million in the quarter versus $573 million in the prior year. Agribusiness adjusted EBIT was $153 million compared to $485 million last year. In Oilseeds, average global soy crush margins were significantly lower than in 2018, driven by a combination of farmer retention soybeans in anticipation of higher prices and soft export demand for soy meal. Results were negatively impacted by approximately $70 million of mark-to-market reversals on soy crush contracts, which favorably impacted Q2. However, a decrease in forward soy crush margins during the third quarter resulted in new mark-to-market gains of approximately $95 million, benefiting our results. As we execute on these contracts, mainly in the fourth quarter, we expect these gains to reverse. Last year's strong performance in oilseeds includes a net mark-to-market gain of approximately $250 million, adding to already stronger margins. Softseed processing results in the quarter were higher than last year, led by Canada and China, as were results in trading and distribution and biodiesel. In Grains, results were lower in both North and South America, primarily due to soft export demand, farmer retention related to the US-China trade dispute and the delayed harvest in the US. Results in ocean freight and trading and distribution were lower than last year. Food & Ingredients adjusted EBIT was $86 million compared to $62 million in Q3 of 2018. Edible Oil results were up $39 million from last year, driven largely by better results in North America and Brazil, benefiting from better supply/demand balance of soy oil as well as improved execution. Bunge Loders Croklaan also contributed to the increased results. Weaker milling results were driven by lower margins in the US and lower volumes and margins in Mexico. Results in Brazil were comparable to last year. Higher results in Sugar & Bioenergy were largely due to $32 million of lower depreciation resulting from the reclassification of the Brazilian sugarcane milling business to held for sale, as well as increased cane crush volumes and higher ethanol prices, which more than offset lower sugar prices. Fertilizer results were in line with the prior year. We reported the tax benefit of $28 million in the third quarter, which included $30 million of favorable resolutions of uncertain tax positions. Based on our current outlook, we expect our effective tax rate to be in the range of 20% to 24% for the full year when excluding notable items. Let's turn to slide 8. Our trailing 12-month adjusted funds from operations were approximately $1 billion. And as you can see on slide 9, our debt largely finances our inventories. Approximately 70% of our net debt was used to finance readily marketable inventories at the end of the quarter. Turning to slide 10, we have committed credit facilities of approximately $5 billion, of which $4.1 billion was available at the end of the quarter, and we had a cash balance of $291 million. Let's turn to slide 11 and our year-to-date summary of capital allocation. Year-to-date, we generated adjusted funds from operations of $854 million. From this total, CapEx spending was $378 million in the first nine months of 2019 compared to $318 million in the first nine months of 2018. Based on our year-to-date spend, full-year CapEx will likely be $520 million to $540 million. It should be noted that about $105 million of our year-to-date and $115 million of our forecast CapEx spending this year relate to the sugarcane milling business, which we're contributing to the JV with BP. We paid $79 million in dividends to shareholders in Q3. This left us with approximately $240 million that we allocated towards debt reduction. Let's turn to slide 12 and our return on invested capital. Our trailing four-quarter average return on invested capital in our core Agribusiness and Food & Ingredients segments was equal to our cost of capital, 7%. Our target is 9%, which is 200 basis points above our WACC. The decline in the trailing four-quarter ROIC from Q2 reflects the unusually strong Q3 in the prior-year that benefitted from the large mark-to-market gain and the higher soy crush margins. With that, I'll turn things back over to Greg for some closing comments.